The Little Detail That Makes Dennis Kimetto’s Chicago Marathon Win Even More Impressive
He pulled off his record-breaking win just six weeks after coming down with malaria. Seriously.
The incredible part of Kimetto’s story doesn’t end there — he is somewhat of an overnight running sensation. From the Chicago Tribune:
As fast as he ran Sunday, it pales in comparison to the pace at which Kimetto, 29, has gone from a non-running subsistence farmer in Eldoret, Kenya, to one of the world’s best marathoners, good enough to earn $100,000 for winning Chicago and a $75,000 bonus for the course record.
On the exhaustive track and road running data base, tilastopaja.net, Kimetto’s competitive record is blank until 2011, when it shows a lone race. Speaking through a Swahili interpreter, Kimetto said he had been growing maize and tending a few cows until he began running about four years ago.
Kimetto said he had been running about four miles a day when a chance encounter with Geoffrey Mutai, a Boston and New York marathon winner, led to an invitation to the demanding Mutai’s training group in a remote area, Kapng’tuny, some 40 miles from Eldoret.
Why Tuberculosis is Having the Worst Week Ever
For an often neglected topic, there’s been lots of news about TB lately. And it’s not the good kind.
Today in the New York Times, the American Enterprise Institute scholar Roger Bate highlighted the pervasiveness of fake TB drugs. Bate references findings from a new study published in the International Journal of Tuberculosis and Lung Disease. The Washington Post got in on the story too.
The Lancet also published a TB study this week showing that an experimental vaccine did not offer more protection than the current TB vaccine used on babies. Just a few of the headlines on this:
- The Scientist: New TB Vaccine Fails Trial
- Think Progress: As Tuberculosis Vaccines Flounder, Developing Nations Join To Fight Drug-Resistant Diseases
- Nature: TB Vaccine Takes a Tumble
So yeah, not a very good week to be in the TB control business.